Putative inflammatory and immunological mechanisms in functional bowel disorders

Bailliere's Best Practice in Clinical Gastroenterology

Volumn 13, Issue 3, 1999, Pages 429-436

  Collins, Stephen M ^a   Vallance, Bruce ^a   Barbara, Giovanni ^b   Borgaonkar, Mark ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Asthma; Colitis; Cytokines; Enteric nerves; Gastroenteritis; Immune system; Infection; Inflammation; Inflammatory bowel disease; Lymphocytes; Mast cells; Sensory nerves; Smooth muscle

Indexed keywords

ENTERITIS; INTESTINE INFECTION; INTESTINE INNERVATION; IRRITABLE COLON; PATHOGENESIS; REVIEW; SENSORIMOTOR FUNCTION;

EID: 0033212818     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0037     Document Type: Article

References (39)

1. Thompson WG, Creed F, Drossman DA et al. Functional bowel disease and functional abdominal pain. Gastroenterology International 1993; 5: 75-91.
2. Thompson GR & Trexler PC. Gastrointestinal structure and function in germ-free or gnotobiotic animals. Gut 1971; 12: 230-235.
3. Abrams GD & Bishop JE. Effect of normal microbial flora on gastrointestinal motility. Proceedings of the Society for Experimental Biology (New York) 1967; 126: 301-304.
4. Hiatt RB & Katz J. Mast cells in inflammatory conditions of the gastrointestinal tract. American Journal of Gastroenterology 1962; 37: 541-548.
5. Weston AP, Biddle WL, Bhatia PS & Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Digestive Diseases and Sciences 1993; 38: 1590-1595.
6. Matter SE, Bhatia PS & Miner PB Jr. Evaluation of antral mast cells in nonulcer dyspepsia. Digestive Diseases and Sciences 1990; 35: 1358-1363.
7. Stead RH, Tomioka M, Quinonez G et al. Intestinal mucosal mast cells in normal and nematode infected rat intestines are in intimate contact with peptidergic nerves. Proceedings of the National Academy of Sciences of the USA 1987; 84: 2975-2979.
8. Shanahan F, Denburg JA, Fox J et al. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release. Journal of Immunology 1985; 135: 1331-1337.
9. Chaudhary NA & Truelove SC. The irritable bowel syndrome. Quarterly Journal of Medicine 1962; 31: 307-322.
10. McKendrick MW & Read NW. Irritable bowel syndrome - Post salmonella infection. Journal of Infection 1994; 29: 1-3.
11. Bergin AJ, Donnelly TC, McKendrick MW & Read NW. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. European Journal of Gastroenterology and Hepatology 1993; 5: 617-620.
12. Neal KR, Hebden J & Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. British Medical Journal 1997; 314: 779-782.
13. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-153 (see Comments).
14. Isgar B, Harman M, Kaye MD & Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983; 24: 190-192.
15. Rao SSC, Read NW, Stobart JAM et al. Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis. Gut 1988; 29: 769-777.
16. Rao SSC, Read NW, Brown C et al. Studies on the mechanism of bowel disturbance in ulcerative colitis. Gastroenterology 1987; 93: 934-940.
17. Loening-Baucke V, Metcalf AM & Shirazi S. Rectosigmoid motility in patients with quiescent and active ulcerative colitis. American Journal of Gastroenterology 1989; 84: 34-39.
18. Collins SM. The immunomodulation of enteric neuromuscular function; implications for motility and inflammatory disorders. Gastroenterology 1996; III: 1683-1689.
19. Burton MB & Gebhart GF. Effects of intracolonic acetic acid on responses to colorectal distension in the rat. Brain Research 1995; 672: 77-82.
20. Morteau O, Hachet T, Caussette M & Bueno L. Experimental colitis alters visceromotor response to colorectal distension in awake rats. Digestive Diseases and Sciences 1994; 39: 1239-1248.
21. Swain MG, Agro A, Blennerhassett P et al. Increased levels of substance P in the myenteric plexus of Trichinella-infected rats. Gastroenterology 1992; 102: 1913-1919.
22. Vermillion DL, Ernst P & Collins SM. T-lymphocyte modulation of intestinal muscle function in the Trichinella-infected rat. Gastroenterology 1991; 101: 31-38.
23. Khan I, Blennerhassett MG, Kataeva GV & Collins SM. Interleukin 1 beta induces the expression of interleukin 6 in rat intestinal smooth muscle cells. Gastroenterology 1995; 108: 1720-1728.
24. Main C, Blennerhassett P & Collins SM. Human recombinant interleukin 1 beta suppresses acetylcholine release from rat myenteric plexus. Gastroenterology 1993; 104: 1648-1654.
25. Hurst SM, Stanisz AM, Sharkey KA & Collins SM. Interleukin 1 beta-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993; 105: 1754-1760.
26. Ruhl A & Collins SM. Enteroglial cells are an integral part of the neuroimmune axis in the gut. Gastroenterology 1995; 108: A680.
27. Barbara G, Vallance BA & Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 1224-1232.
28. Barbara G, Blennerhassett PA & Collins SM. On the mechanism underlying post-infective intestinal dysfunction. Gastroenterology 1998; 114: G2966 (Abstract).
29. Collins SM, McHugh K, Jacobson K et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996; 111: 1509-1515.
30. Kennedy P & Cello R. Colitis of boxer dogs. Gastroenterology 1966; 51: 926-931.
31. Stout C & Snyder R. Ulcerative colitis-like lesions in Siamong gibbons. Gastroenterology 1969; 57: 256-261.
32. Qiu B, Vallance B, Blennerhassett P et al. The susceptibility to stress-induced reactivation of colitis requires CD4+ve but not CD8+ve T lymphocytes. Gastroenterology 1998; 114: A1065 (Abstract).
33. Gue M, Bonbonne C, Fioramonti J et al. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. American Journal of Physiology 1997; 272: G84-G91.
34. Sternberg EM, Chrousos GP, Wilder RL & Gold PW. The stress response and the regulation of inflammatory disease. Annals of Internal Medicine 1992; 117(10): 854-866.
35. Fielding JF & Doyle GD. The prevalence and significance of gastritis in patients with lower intestinal irritable bowel (irritable colon) syndrome. Journal of Clinical Gastroenterology 1982; 4: 507-510.
36. Collins JS, Hamilton PW, Watt PC et al. Quantitative histological study of mucosal inflammatory cell densities in endoscopic duodenal biopsy specimens from dyspeptic patients using computer linked image analysis. Gut 1990; 31(8): 858-861.
37. Salzmann JL, Peltier-Koch F, Bloch F et al. Methods in laboratory investigation: Morphometric study of colonic biopsies: A new method of estimating inflammatory diseases. Laboratory Investigation 1992; 60: 847-851.
38. Seth R, Vantier G, McLaughlin J et al. Correlation between IL-8, INF-gamma, IL-10 mRNA levels and histological activity in IBD. Gut 1995; 109.
39. Khan I & Collins SM. Is there an inflammatory basis for a subset of patients presenting with diarrhea in the irritable bowel syndrome. Gastroenterology 1994; 106: A523 (Abstract).